Congratulations to Dr. Bachier and the Northside Immunotherapy Program Clinical Research Team on Their Collaborative Poster Presentations at the 2026 ASCO and European Hematology Association Annual Meetings

We congratulate Dr. Bachier and the Northside Immunotherapy Program Clinical Research Team on the presentation of their collaborative research posters at the 2026 American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) Annual Meetings.

We also extend our sincere appreciation to Kite, a Gilead company, and Bristal Myers Squibb for their continued partnership and support of our Immunotherapy Program. Through these collaboration, we can offer patients access to state-of-the-art clinical research trials and commercially available CAR T-cell therapies, helping advance innovative treatment options and improve patient outcomes.

ASCO 2026 Collaborative Poster Presentations

Outcomes of lisocabtagene maraleucel (liso-ce) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): First real-world data from the CIBMTR,

Jennifer J. Huang, Taylor Brooks, Jason Romancik, Michael Wang, Elise A. Chong, Uttam Rao, Lizamarie Bachier, Amitkumar Mehta, Matthew A. Lunning, David Bernasconi, Lin Wang, Kartik Patel, Debasmita Roy, Samantha M. Jaglowski, Bradley Hunter, Iris Isufi

KITE-753: A phase 2 study of an autologous anti-CD19/CD20 CAR T-cell therapy in CAR-naive patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL), Saurabh Dahiya, Timothy Voorhees, Matthew Ulrickson, Jean Yared, Patrick M. Reagan, Marie J. Kersten, Max S. Topp, Lizamarie Bachier, Michael D. Jain, Andrew P. Jallouk, Andre Goy, Ran Reshef, Cameron Turtle, Gary Simmons, Justyna Kanska, Jinghui Dong, Will Watts, Sara Beygi, Myrna Nahas, Sairah Ahmed

2026 European Hematology Association Annual Congress: Collaborative Poster Presentations

A phase 1 study of KITE-753 in patients (PTS) with relapsed/relapsed/refractory (R/R) B-cell Lymphoma: Updated safety and efficacy results, Saurabh Dahiya, Matthew Ulrickson, Jean A. Yared, Patrick Reagan, Timothy Voorhees, Andre Goy, Cameron Turtle, Lizamarie Bachier-Rodriguez, Gary Simmons, Ran Reshef, Marie José Kersten, Max Topp, Robin Sanderson, Loretta Nastoupil, A. Scott Jung, Jinghui Dong, Joshua Winters, Rhine Shen, Justyna Kanska, Myrna Nahas, Sairah Ahmed

Outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): first real-world data from the CIBMTR, Jennifer Huang, Taylor Brooks, Jason Romancik, Michael L. Wang, Elise Chong, Uttam Rao, Lizamarie Bachier-Rodriguez, Amitkumar Mehta, Matthew Lunning, David Bernasconi, Lin Wang, Kartik Patel, Debasmita Roy, Samantha Jaglowski, Bradley D. Hunter, Iris Isufi.